Method for treating an autoimmune neurological disease and/or neurodegenerative disease and pharmaceutical formulations for a liquid dosage form and a controlled release dosage form

A method for treating an autoimmune neurological disease and/or a neurodegenerative disease is provided. The method includes administering an effective amount of at least one compound having Formula (I), Formula (II) or Formula (III), or its geometric isomer, enantiomer or diastereomer to a subject...

Full description

Saved in:
Bibliographic Details
Main Authors Wen, Shu-Fang, Lin, Meng-Nan, Huang, Kuo-Kuei, Yang, Ya-Yan, Lu, Chu-Hsun, Lu, I-Huang, Kuo, Zong-Keng, Lee, Tze-Chung, Liaw, Jia-Horng, Lin, Pei-Hsin, Pan, I-Hong
Format Patent
LanguageEnglish
Published 02.08.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A method for treating an autoimmune neurological disease and/or a neurodegenerative disease is provided. The method includes administering an effective amount of at least one compound having Formula (I), Formula (II) or Formula (III), or its geometric isomer, enantiomer or diastereomer to a subject in need thereof:wherein is a single or double bond, X is NCH3 or CH2, Y is null, O or N, Z is O or N, R1 is H, OH, and R2 is null, H, C1-C8 alkyl, -(C═O)-alkyl, -(C═O)-aryl, -(C═O)-alkyl-aryl, -(C═O)-heteroaryl, cycloalkyl or heterocycloalkyl, which optionally substituted by one or more of -OH, -NO2, -NH2, -NR3R4, carbonyl, alkoxyl, alkyl or -OCF3, wherein R3 and R4 independently are H, alkyl, -SO2CH3, -(C═O)-CH3 or -(C═O)-NH2.
Bibliography:Application Number: US201816023940